acamprosate has been researched along with Depressive Disorder, Major in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biernacka, J; Choi, DS; Frye, M; Geske, JR; Ho, MF; Karpyak, VM; Li, H; Moon, I; Wei, L; Weinshilboum, R; Wen, Z; Zhang, C; Zhang, L; Zhou, Y | 1 |
| Helton, SG; Lohoff, FW | 1 |
| Raj, YP | 1 |
| Baer, L; Bentley, K; Clain, AJ; Evins, AE; Fava, M; Mischoulon, D; Pedrelli, P; Witte, J | 1 |
| Sher, L | 1 |
2 review(s) available for acamprosate and Depressive Disorder, Major
| Article | Year |
|---|---|
Pharmacogenetics of alcohol use disorders and comorbid psychiatric disorders.
Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Anxiety Disorders; Comorbidity; Depressive Disorder, Major; Disulfiram; Fructose; Humans; Naltrexone; Pharmacogenetics; Precision Medicine; Taurine; Topiramate; United States | 2015 |
Alcoholism and suicidal behavior: a clinical overview.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Antidepressive Agents, Tricyclic; Anxiety; Comorbidity; Depressive Disorder, Major; Humans; Hydroxyindoleacetic Acid; Naltrexone; Narcotic Antagonists; Personality Disorders; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Suicide; Suicide, Attempted; Taurine | 2006 |
1 trial(s) available for acamprosate and Depressive Disorder, Major
| Article | Year |
|---|---|
A randomized, controlled, pilot study of acamprosate added to escitalopram in adults with major depressive disorder and alcohol use disorder.
Topics: Acamprosate; Adult; Alcoholism; Citalopram; Depressive Disorder, Major; Diagnosis, Dual (Psychiatry); Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pilot Projects; Taurine; Treatment Outcome | 2012 |
2 other study(ies) available for acamprosate and Depressive Disorder, Major
| Article | Year |
|---|---|
TSPAN5 influences serotonin and kynurenine: pharmacogenomic mechanisms related to alcohol use disorder and acamprosate treatment response.
Topics: Acamprosate; Alcohol Drinking; Alcoholism; Depressive Disorder, Major; Humans; Induced Pluripotent Stem Cells; Kynurenine; Neuroinflammatory Diseases; Pharmacogenetics; Serotonin; Tetraspanins; Tryptophan Hydroxylase | 2021 |
Gambling on acamprosate: a case report.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Antidepressive Agents, Second-Generation; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Disruptive, Impulse Control, and Conduct Disorders; Drug Therapy, Combination; Female; Follow-Up Studies; Gambling; Humans; Middle Aged; Taurine; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |